Withdrawn application: BiResp Spiromax, 27/04/2026

BiResp Spiromax - withdrawal of application for variation to marketing authorisation Application withdrawn The application for a change to this medicine's authorisation has been withdrawn budesonide / formoterol Post-authorisation Human